Related Experiment Video
Updated: May 18, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature
Bettina M Knoll1, Matt Hellmann, Camille N Kotton
1Department of Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. bknoll@partners.org
Background:
Vancomycin-resistant Enterococcus faecium (VR E. faecium) is a rare cause of meningitis and is associated with substantial mortality. Limited therapeutic options are available for the treatment of VR E. faecium meningitis. The optimum therapy has not been established.
Methods:
We retrospectively identified adult cases of meningitis due to VR E. faecium that occurred at the Massachusetts General Hospital from 1999 to 2011 and performed a literature search for published adult cases using Medline and Embase.
Results:
At our institution, 4 cases of meningitis due to VR E. faecium were identified. Three out of our 4 cases were successfully treated with linezolid in combination with rifampicin, or with daptomycin in combination with quinupristin-dalfopristin (QD), and 1 out of 4 with linezolid monotherapy. The literature search yielded 18 cases published to date. Published cases showed bacterial cure with linezolid, chloramphenicol or QD (intravenous (IV) and intrathecal (IT)) monotherapy, or linezolid in combination with ampicillin, gentamicin, rifampicin or chloramphenicol, or daptomycin in combination with gentamicin or QD.
Conclusions:
Bacterial cure of meningitis due to VR E. faecium can be achieved with various antimicrobial drugs used as monotherapy or in combination. IT in addition to IV therapy should be considered dependent on the pharmacological properties of the drugs. We also reported the successful treatment of a case with a vancomycin-resistant, linezolid-intermediate isolate with QD and daptomycin. The paucity of cases with this clinical syndrome does not allow the identification of an optimal treatment regimen.
Insights
Vancomycin-resistant Enterococcus faecium meningitis is rare but deadly. Various drug combinations, including linezolid and daptomycin, show promise for bacterial cure, though an optimal regimen remains elusive.
Area of Science:
- Infectious Diseases
- Neuroscience
- Pharmacology
Background:
- Vancomycin-resistant Enterococcus faecium (VRE) meningitis is a rare but severe infection with high mortality.
- Limited therapeutic options exist for treating VRE meningitis, and optimal treatment strategies are not well-established.
Observation:
- A retrospective review identified 4 adult cases of VRE meningitis at Massachusetts General Hospital (1999-2011).
- A literature search identified 18 additional published cases of VRE meningitis.
Findings:
- Successful treatment of VRE meningitis was achieved with various antimicrobial agents, including linezolid, daptomycin, quinupristin-dalfopristin (QD), and chloramphenicol.
- Treatment regimens included monotherapy and combination therapy, with intravenous (IV) and intrathecal (IT) administration considered.
- One case with a vancomycin-resistant, linezolid-intermediate isolate was successfully treated with QD and daptomycin.
Implications:
- Bacterial cure for VRE meningitis is achievable with diverse antimicrobial strategies.
- The choice of therapy, including IV and IT routes, should consider drug properties.
- The rarity of VRE meningitis precludes definitive identification of an optimal treatment regimen.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Mechanism of Antibiotic Resistance in MRSA
Viral Meningitis
Endocarditis III: Medical Management